Northwestern Mutual Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155	Buy	+3	New	+$153	﹤0.01%	3963
2025 Q3	–	Sell	-122	Closed	-$3.85K	–	4044
2025 Q2	$3.85K	Hold	122	–	–	﹤0.01%	3087
2025 Q1	$4K	Hold	122	–	–	﹤0.01%	3003
2024 Q4	$4.41K	Buy	122 +59	+94%	+$2.08K	﹤0.01%	2983
2024 Q3	$1.96K	Buy	+63	New	+$1.97K	﹤0.01%	3121
2022 Q3	–	Sell	-80	Closed	-$2K	–	3385
2022 Q2	$2K	Buy	+80	New	+$2.29K	﹤0.01%	2949
2021 Q3	–	Sell	-86	Closed	-$3K	–	3210
2021 Q2	$3K	Buy	+86	New	+$2.64K	﹤0.01%	2762
2020 Q2	–	Sell	-80	Closed	-$1K	–	2680
2020 Q1	$1K	Buy	+80	New	+$1.68K	﹤0.01%	2464
2019 Q3	–	Sell	-98	Closed	-$3K	–	2677
2019 Q2	$3K	Buy	98 +53	+118%	+$1.82K	﹤0.01%	2252
2019 Q1	$2K	Buy	+45	New	+$1.67K	﹤0.01%	2341
2017 Q1	–	Sell	-518	Closed	-$13K	–	2374
2016 Q4	$13K	Buy	+518	New	+$11.6K	﹤0.01%	1519
2016 Q3	–	Sell	-569	Closed	-$12K	–	1366
2016 Q2	$12K	Sell	569 -109	-16%	-$1.93K	﹤0.01%	1315
2016 Q1	$10K	Buy	+678	New	+$8.85K	﹤0.01%	1451

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwestern Mutual Wealth Management's SUPN Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 3 shares worth $155. The stake represents ﹤0.01% of the portfolio and ranks #3963 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in SUPN as recently as Q2 2025.

Northwestern Mutual Wealth Management first reported a position in SUPN in Q1 2016 and has held it in 13 quarters since. The position peaked at $13K in Q4 2016. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

Northwestern Mutual Wealth Management held 3 shares of Supernus Pharmaceuticals worth $155 as of Q1 2026.
Supernus Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q1 2026.
Supernus Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3963 holding.
Northwestern Mutual Wealth Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and has held it in 13 quarters since.
Northwestern Mutual Wealth Management's Supernus Pharmaceuticals position peaked at $13K in Q4 2016.
327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.